tirzepatide mess with your period Can Mounjaro affect periods? Period Cycle Changes - Interesting

Understanding that continued medication use will likely be necessary helps frame expectations appropriately

How employers can manage the next phase of GLP-1 expansion Beyond 2026, GLP-1s are also being explored for their potential in other areas, such as cancer, addiction, and more, with rapidly changing dynamics

Retatrutide's Phase 2 trial reported nausea in approximately 45 to 58% of participants at the 8 mg and 12 mg doses, with vomiting in 20 to 30%

Research models evaluate their interaction with glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor systems to better understand peptide-mediated metabolic behavior